CN1059831C - Traditional Chinese medicine preparation for treating leukocythemia - Google Patents
Traditional Chinese medicine preparation for treating leukocythemia Download PDFInfo
- Publication number
- CN1059831C CN1059831C CN98113853A CN98113853A CN1059831C CN 1059831 C CN1059831 C CN 1059831C CN 98113853 A CN98113853 A CN 98113853A CN 98113853 A CN98113853 A CN 98113853A CN 1059831 C CN1059831 C CN 1059831C
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine preparation
- present
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a traditional Chinese medicine preparation for treating leucocythemia, which is characterized in that the present invention has the recipe and the proportions of parts by weight of components of 5 to 15 of milk vetch, 3 to 7 of angelica, 3 to 7 of donkey-hide gelatin, 1 to 5 of bezoar, 5 to 15 of snow lotus, 2 to 6 of saffron, 2 to 7 of ganoderma, 3 to 8 of antelope horn, 3 to 8 of aweto, 3 to 7 of natural indigo, 3 to 7 of realgar and 5 to 15 of rhodiola root. The present invention directly inhibits the generation of infantile cancer cells in spinal cord to make a hematogenesis function recover to normality. The present invention has the advantages of good therapeutic effect and high cure rate.
Description
The present invention relates to a kind of Chinese medicine preparation, the leukemic Chinese medicine preparation of particularly a kind of treatment.
Leukemia is that pathological changes appears in the hemopoietic system of human body, its cause of disease and pathogeny also imperfectly understand, by clinical practice for many years and according to hematopathy data prompting both at home and abroad, the leukemic cause of disease is a lot, but studying the more concentrated and sure cause of disease is viral infection, also having some chemical drugs, ionizing radiation etc., is the clue of leukemic some inherited genetic factors for acute leukemia and chronic lymphatic.Blood is the ingredient of human body, the abundant nutrition that it carries human body to need, keep the normal function of each histoorgan, blood is ill, each organ of the whole body is got involved and morbid state occurred, comprise that mainly each internal organs such as the heart, liver,spleen,kidney, lung are encroached on, different clinical symptoms occur, as aroused in interestly overrun, splenomegaly, renal failure, respiratory failure etc.; The hemopoietic organ of human body is the organ that generates blood cell, mainly comprise hemopoietic tissue such as bone marrow, thymus, lymph node, liver, spleen, leukemia is a malignant tumor of hematopoiesis system, it is certain a series of hemocyte neoplasm, its soaks in each histoorgan of whole body, clinically now mainly is: anemia, fever, hemorrhage, liver spleen and lymph enlargement, a large amount of leukaemias, juvenile cell active proliferation can occur in blood and the bone marrow on every side.For leukemic Therapeutic Method, doctor trained in Western medicine is mainly taked the bone marrow transplantation method, expense height, patient suffering; And the traditional Chinese medical science mainly adopts Drug therapy, and general effect is also undesirable.
Purpose of the present invention provides a kind of treatment leukemic Chinese medicine preparation, and the inmature cancerous cell that can directly suppress in the spinal cord generates, and makes the hemopoietic functional recovery normal, and therapeutic effect is good, the cure rate height.
The object of the present invention is achieved like this: it adopts following materials of weight proportions to make pill:
The Radix Astragali 10 Radix Angelicae Sinensis 5.5
Colla Corii Asini 5 Radix Rhodiolaes 9
Calculus Bovis 3 Herba Saussureae Involueratae 6
Stigma Croci 3 Ganodermas 2
Cornu Saigae Tataricae 4 Cordycepss 5
Indigo Naturalis 5 Realgars 3
Radix Sophorae Tonkinensis 10 Radix Glycyrrhizaes 10
Radix Salviae Miltiorrhizae 4 Olibanums 4
Sanguis Draxonis 6 Myrrhas 5
Palm fibre charcoal 7 Radix Platycodoniss 4
Fructus Forsythiae 3 Radix Arnebiae (Radix Lithospermi)s 4
Rhizoma Cimicifugae 4 Rhizoma Coptidis 4
Radix Scutellariae 6 Herba Scutellariae Barbataes 8
Rhizoma Dioscoreae Bulbiferae 9 Cinnabaris 6
Margarita 1 Mentholum 4
In above-mentioned prescription, wherein the Radix Astragali has blood pressure lowering and bacteriostasis; Colla Corii Asini contains several amino acids, can make the increased blood pressure of retouching of wound shock, and the generation of erythrocyte pigment is had facilitation, and serum calcium is increased; Radix Rhodiolae contains rhodioloside and to butyl alcohol, still contains tannin, flavone compound and micro-volatile oil in addition, also contains the trace element of multiple biologically actives such as ferrum, zinc, silver, and contains a small amount of biological alkali.Have tangible oxygen lack resistant function, antifatigue effect, antitoxic action, two-way conciliation effect plays regulating action to nerve, and the human body substance metabolism is played obvious effect, hormonal system is had the smart phase of excited peace, and do not have toxicity; Calculus Bovis contains cholic acid, deoxycholic acid, also contains elements such as bilirubin, cholesterol, vitamin A and calcium, ferrum, zinc, has effects such as analgesic, anti-cold, function of gallbladder promoting and blood pressure lowering; Cornu Saigae Tataricae contains keratin, calcium phosphate and inorganic salt etc., has antipyretic effect; Herba Saussureae Involueratae has heat-clearing and toxic substances removing, the meridian dredging and anastalsis; Cordyceps contains crude protein 25-32%, and hydrolyzate is the mixture of several amino acids, and is still fatty 80%, and wherein big is unsaturated fatty acid, human body is had the effect of flat nourishing YIN sun; Indigo Naturalis has cooling blood and dissolving purpura, antipyretic and antidote functions, owing to include indirubin, with controlling chronic myelocytic leukemia certain curative effect is arranged; Realgar has detoxifcation parasite killing, the dampness using warming therapy merit of dispelling, and leukemia is had obvious curative effects; Radix Sophorae Tonkinensis contains chemical compounds such as matrine and the plain bavin Tan Su of Progesterone, through zoopery and clinical proof antitumaous effect is arranged, and malignant tumor is had certain inhibitory action.
Advantage of the present invention is: the fine inmature cancerous cell of controlling in the spinal cord of energy, and blood is normally generated, thereby recover each organ function of health, therapeutic effect is good, the cure rate height.
Provide specific embodiments of the invention below.
Embodiment 1
The part by weight of each composition is as follows:
The Radix Astragali 10 Radix Angelicae Sinensis 5.5
Colla Corii Asini 5 Radix Rhodiolaes 9
Calculus Bovis 3 Herba Saussureae Involueratae 6
Stigma Croci 3 Ganodermas 2
Cornu Saigae Tataricae 4 Cordycepss 5
Indigo Naturalis 5 Realgars 3
Radix Sophorae Tonkinensis 10 Radix Glycyrrhizaes 10
Radix Salviae Miltiorrhizae 4 Olibanums 4
Sanguis Draxonis 6 Myrrhas 5
Palm fibre charcoal 7 Radix Platycodoniss 4
Fructus Forsythiae 3 Radix Arnebiae (Radix Lithospermi)s 4
Rhizoma Cimicifugae 4 Rhizoma Coptidis 4
Radix Scutellariae 6 Herba Scutellariae Barbataes 8
Rhizoma Dioscoreae Bulbiferae 9 Cinnabaris 6
Margarita 1 Mentholum 4.
After said components taken by weighing by weight, the honeyed pill production technology produced honeyed pill and gets final product routinely.
Claims (1)
1. leukemic Chinese medicine preparation of treatment is characterized in that it adopts following materials of weight proportions to make pill:
The Radix Astragali 10 Radix Angelicae Sinensis 5.5
Colla Corii Asini 5 Radix Rhodiolaes 9
Calculus Bovis 3 Herba Saussureae Involueratae 6
Stigma Croci 3 Ganodermas 2
Cornu Saigae Tataricae 4 Cordycepss 5
Indigo Naturalis 5 Realgars 3
Radix Sophorae Tonkinensis 10 Radix Glycyrrhizaes 10
Radix Salviae Miltiorrhizae 4 Olibanums 4
Sanguis Draxonis 6 Myrrhas 5
Palm fibre charcoal 7 Radix Platycodoniss 4
Fructus Forsythiae 3 Radix Arnebiae (Radix Lithospermi)s 4
Rhizoma Cimicifugae 4 Rhizoma Coptidis 4
Radix Scutellariae 6 Herba Scutellariae Barbataes 8
Rhizoma Dioscoreae Bulbiferae 9 Cinnabaris 6
Margarita 1 Mentholum 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98113853A CN1059831C (en) | 1998-03-20 | 1998-03-20 | Traditional Chinese medicine preparation for treating leukocythemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98113853A CN1059831C (en) | 1998-03-20 | 1998-03-20 | Traditional Chinese medicine preparation for treating leukocythemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1196263A CN1196263A (en) | 1998-10-21 |
| CN1059831C true CN1059831C (en) | 2000-12-27 |
Family
ID=5223551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98113853A Expired - Fee Related CN1059831C (en) | 1998-03-20 | 1998-03-20 | Traditional Chinese medicine preparation for treating leukocythemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1059831C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101161265B (en) * | 2006-12-18 | 2010-04-07 | 惠庆海 | Medicament taken orally for treating aplastic anemia |
| CN101214320B (en) * | 2008-01-07 | 2011-01-19 | 姚万英 | Medicament for treating leukemia and preparation thereof |
| CN101890042B (en) * | 2009-05-18 | 2013-06-19 | 上海交通大学医学院附属瑞金医院 | Chinese medicinal compound preparation arsenic tetrasulfide-tanshinone-indirubin and preparation method thereof and application thereof in preparing antineoplastic agents |
| CN103860660B (en) * | 2012-12-14 | 2016-12-21 | 陕西郝其军制药股份有限公司 | A kind of medicine treating acute and chronic leukemia and preparation method thereof |
-
1998
- 1998-03-20 CN CN98113853A patent/CN1059831C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 兰州学院学报1993,19(1) 1993.1.1 王镜等 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1196263A (en) | 1998-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102100735B (en) | Medicinal composition for treating skin diseases | |
| CN1048156C (en) | Ginseng and astragalus trichogen | |
| CN1059831C (en) | Traditional Chinese medicine preparation for treating leukocythemia | |
| CN1052164C (en) | Chinese medicinal preparation for senile dementia | |
| CN1272066C (en) | Medicinal composition for relieving itching | |
| CN1272027C (en) | Desmodium preparation for treating urinary calculus, infection and cholelithiasis cholecy stolithiasis and chole cystitis and its production method | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN1177598C (en) | Medicine for eliminating side effect of radiotherapy and chemotherapy to treat malignant tumor and its prepn | |
| CN1341436A (en) | Eexternal-use Chinese medicine plaster for curing deafness and tinnitus | |
| CN1148214C (en) | Medicine for curing bronchial asthma disease and its preparing method | |
| CN1931300A (en) | Externally applied medicine for treating women's dysmenorrhea | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1059117C (en) | Katsutoxin pill for tumor and preparing method thereof | |
| CN1618439A (en) | Broad-specturm medicine for treating snake venom poisoning | |
| CN1186060C (en) | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method | |
| CN1317007C (en) | Pearl detoxifying oral liquid and preparing method tehreof | |
| CN1058631C (en) | Psoriasis capsule | |
| CN1049825C (en) | Chinese medicinal compound "Tiancixueyuan" and it prepn. technique | |
| CN1136894C (en) | Medicinal composition for treating tuberculosis and its preparing process | |
| CN1049139C (en) | Application 'Xintie'an' of curing heart disease and preparing process thereof | |
| CN101181551B (en) | Externally used unction for curing hemorrhoid | |
| CN1204911C (en) | Orally taken Chinese medicine for treating endocrine dyscrasia | |
| CN1911357A (en) | Medicinal composition for treating hyperosteogency | |
| CN1739749A (en) | Leukemia treating Chinese medicine composition and its prepn | |
| CN1102407C (en) | Antidepressive capsule and preparing process thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20001227 Termination date: 20120320 |